DCF — ATRIUM HEALTH PINEVILLE
Enterprise Value: $366.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$366.6M
Enterprise Value
$93.3M
PV of Cash Flows
$273.3M
PV of Terminal Value
$440.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $592.4M | $50.4M | 9.0% | $16.4M | $14.9M |
| Year 2 | $610.2M | $58.0M | 10.0% | $21.5M | $17.7M |
| Year 3 | $628.5M | $66.0M | 11.0% | $26.8M | $20.1M |
| Year 4 | $647.3M | $71.2M | 11.0% | $30.0M | $20.5M |
| Year 5 | $666.8M | $75.0M | 11.0% | $32.2M | $20.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $366.6M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$575.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0800000001390945
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5